ABCL (AbCellera Biologics) Sof foyda

ABCL (AbCellera Corp) - kompaniyaning tovar belgisi

AbCellera Biologics (ABCL) antitanalar kashf qilish uchun yopiq AI muhitini boshqaradi, bu esa sog'liqni saqlash gigantlari uchun texnologik hamkorlarni almashtirishni o'ta qimmat qiladi. Biznesning daromadliligi sog'liqni saqlash gigantlari bilan hamkorlikdan tushadigan litsenziya to'lovlariga va o'z dori vositalarini ishlab chiqishga bog'liq. GURU.Markets platformasidagi narxlar dinamikasi, u yerda foyda ko'rsatkichi -0.16 darajasida turibdi, xodimlar barqarorligi bilan to'ldirilgan, chunki kompaniya bioinformatika va IT chorrahasidagi noyob mutaxassislarni muvaffaqiyatli saqlab qolmoqda.

ABCL (AbCellera) Sof foyda tarixi 04.07.2022dan 31.10.2026gacha

AbCellera Corp (ABCL) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari AbCellera Biologics Inc.|ABCL - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi AbCellera Bio|ABCL - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati AbCellera|ABCL - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi abcellera.com|ABCL - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati AbCellera Biologics|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati AbCellera Bio|ABCL - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar AbCellera Bio|ABCL - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi AbCellera|Shoshilinch likvidlik abcellera.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ABCL - Sof foyda
Kompaniyaning jamlanma tahlili:AbCellera Biologics
AbCellera Biologics asosiy tovari

Ushbu ko'rsatkich ob'ektiv daromadlilikni bozor o'sishi kutib qolinishlaridan ajratgan holda umumiy moliyaviy natijani o'lchaydi. Kompaniyaning haqiqiy foydasini tahlil qilish egri chiziqdagi mahalliy pasayishlar orqali yashirin operatsion nosozliklarni aniqlash imkonini beradi. Metrikaning barqarorligi biznes modelining chidamliligini va korxonaning fundamental holatini tasdiqlaydi. AbCellera Biologics (ABCL) uchun bu uning noyob mikrofluidik skriningining monetizatsiya samaradorligini aks ettiradi. Proprietary AI platformasi foydani bevosita bozor raqobatidan himoya qilishni ta'minlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|Pharming - Sof foyda|NKTR - Sof foyda|UPB: Sof foyda|ZBIO (zenasbio.com) - Kompaniyaning sof foydasi|IMNM (Immunome) - Sof foyda|Sof daromad Gossamer Bio Inc (GOSS)|Sof foyda KALV|SEPN - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|savarapharma.com - Kompaniyaning sof foydasi|RIGL - Kompaniyaning sof foydasi|ANAB: Kompaniyaning sof foydasi|ATXS: Sof foyda|Kompaniyaning sof daromadi enGene Corp (ENGN)|Kompaniyaning sof foydasi RAPT Therapeutics, Inc.|JBIO: Yakuniy foyda|Sof foyda ACRS|Sof foyda Kyverna Therapeutics Inc. (KYTX)|Tiziana Life Sciences PLC - Sof daromad|Yakuniy foyda CABA|Ventyx Biosciences - Sof foyda|THTX: Kompaniyaning sof foydasi|AVTX: Sof foyda|ELDN - Sof moliyaviy natija|Kompaniyaning sof foydasi Agenus Inc|Kompaniyaning sof daromadi Climb Bio, Inc CLYM|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|Kompaniyaning sof foydasi ATYR (atyrpharma.com)|Kompaniyaning sof foydasi Adagene Inc. ADAG|ImageneBio (IMA) - Kompaniyaning sof daromadi|Shattuck Therapeutics - Sof foyda|Yillik sof foyda Equillium, Inc. (EQ)|CNTB: Sof foyda|IMUX - Sof moliyaviy natija|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|Sof daromad InflaRx GmbH (IFRX)|Kompaniyaning sof foydasi X4 Pharma (XFOR)|Sof moliyaviy natija adicetbio.com|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|Barinthus Biotherapeutics plc - Sof foyda|KZR: Kompaniyaning sof foydasi|SABS: Sof foyda|Sof daromad Akari Therapeutics, Plc|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Kompaniyaning sof foydasi QTTB|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA: Soliqdan keyingi foyda|Sof foyda IBIO (iBio Corp)|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Aptevo Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Vyome Holdings - Sof daromad|Yakuniy foyda REVB|Indaptus - Sof foyda|Sof moliyaviy natija BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof daromad IGMS (IGM Biosciences, Inc.)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP: Kompaniya foydasi|Third Harmonic Bio, Inc. - Sof foyda